secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-08-13T23:59:59+00:00
Accession:  0001140361-24-036929
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Q2 revenue $7.2M (+53% YoY); guides Q3 growth 65-75%
-------------------------------------------------------------

- Q2 revenue $7.2M, up 53% YoY; 72 UltraMist systems sold vs 49 in Q2 2023.
- GAAP operating income $2.0M; net income $6.6M vs loss $7.3M YoY.
- Adjusted EBITDA $1.5M vs $171K YoY; year-to-date $1.4M vs -$1.6M.
- Q3 2024 revenue guidance $8-8.5M (65-75% growth); gross margin mid 70s.
- Reverse stock split approved, note/warrant exchange fully subscribed to simplify cap structure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124036929/0001140361-24-036929-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124036929/ef20033924_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-036929

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer